Ergomed plc Ergomed Award of Share Options (9186C)
June 16 2023 - 2:00AM
UK Regulatory
TIDMERGO
RNS Number : 9186C
Ergomed plc
16 June 2023
PRESS RELEASE
Ergomed Award of Share Options
Guildford, UK - 16 June 2023: Ergomed plc (LSE: ERGO) ("Ergomed"
or the "Company"), a company focused on providing specialised
services to the pharmaceutical industry, today announces that the
following LTIP (Long Term Incentive Plan) awards were made to
Jonathan Curtain (Chief Financial Officer) on 15 June 2023.
Mr Curtain was awarded a total of 28,866 options over the
Company's ordinary shares. The options have an exercise price of 1
pence per share. Of the total option award to Mr Curtain, 75% will
vest three years after the grant date, conditional upon the
achievement of total shareholder return of 15% (compounded annual
growth rate). The remaining 25% will vest three years after the
grant date subject to continued employment. The option grant
comprises annual discretionary LTIP awards for which Mr Curtain is
eligible.
The notification below, made in accordance with the requirements
of Article 19 of the UK Market Abuse Regulation, provides further
detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
Details of the person discharging managerial responsibilities/person
1 closely associated
-----------------------------------------------------------------------------------
a) Name Jonathan Curtain
--------------------------------- ------------------------------------------------
Reason for the notification
2
-----------------------------------------------------------------------------------
a) Position/status Chief Financial Officer
--------------------------------- ------------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------------- ------------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------
a) Name Ergomed plc
--------------------------------- ------------------------------------------------
b) Legal Entity 213800BVS8I9VMC1AP84
Identifier
--------------------------------- ------------------------------------------------
Details of the transaction(s): section to be repeated for
4 (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------------------
a) Description of Options over ordinary shares of 1 pence each
the financial
instrument, type
of instrument GB00BN7ZCY67
Identification
code
--------------------------------- ------------------------------------------------
b) Nature of the Grant of options under the Company's Long
transaction Term Incentive Plan
--------------------------------- ------------------------------------------------
c) Currency GBP
--------------------------------- ------------------------------------------------
d) Price(s) and Price(s) Volume(s)
volume(s)
--------------------------------- ------------------------------- ---------------
1 pence 28,866
---------------------------------------------------------------------- ---------------
e) Aggregated information Options over 28,866 ordinary shares at an
- Aggregated exercise price of 1 pence per share
volume
- Price
- Aggregated
total
--------------------------------- ------------------------------------------------
f) Date of the transaction 15 June 2023
--------------------------------- ------------------------------------------------
g) Place of the Outside a trading venue
transaction
--------------------------------- ------------------------------------------------
ENDS
Enquiries :
Ergomed plc Tel: +44 (0) 1483 402 975
Dr Miroslav Reljanović (Executive Chairman)
Jonathan Curtain (Chief Financial Officer)
Keith Byrne (Senior Vice-President, Capital Markets and
Strategy)
Numis Securities Limited (Nominated Advisor and Joint Tel: +44 (0) 20 7260 1000
Broker)
Freddie Barnfield / Euan Brown/ Jack McLaren
Peel Hunt Securities Limited (Joint Broker) Tel: +44 (0) 20 7418 8900
James Steel / Dr Christopher Golden
Consilium Strategic Communications - for UK enquiries Tel: +44 (0) 20 3709 5700
Chris Gardner / Matthew Neal ergomed@consilium-comms.com
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical
industry spanning all phases of clinical development, post-approval
pharmacovigilance and medical information. Ergomed's fast-growing
services business includes an industry-leading suite of specialist
pharmacovigilance (PV) solutions, integrated under the
PrimeVigilance brand, a full range of high-quality clinical
research and trial management services under the Ergomed brand
(CRO) and mission-critical regulatory compliance and consulting
services under the ADAMAS brand. For further information, visit:
http://ergomedplc.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHUVOKROKUNAAR
(END) Dow Jones Newswires
June 16, 2023 02:00 ET (06:00 GMT)
Ergomed (LSE:ERGO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ergomed (LSE:ERGO)
Historical Stock Chart
From Jul 2023 to Jul 2024
